Lipid-Based Nanocarriers and Applications in Medicine

Author:

Fulden Aydın Ümmühan1,Tuli Abdullah1

Affiliation:

1. Çukurova University, Faculty of Medicine, Medical Biochemistry Department, Adana, Turkey

Abstract

Lipid nanocarriers have recently arisen with a wide range of uses and research areas, with the advantages they offer in virtue of their unique properties. They are easily synthesized, scaled up, biodegradable, proper to transport many bioactive components, have a high loading capacity, and are convenient for various routes of administration (parenteral, oral, dermal, ocular, etc.). These carriers overcome the problems of bioactive substances such as low solubility, plasma half-life and bioavailability, and side effects, as well as providing controlled release, local delivery, and targeting. Lipid-based nanoparticular systems can be categorized into two basic classes, vesicular and non-vesicular. While liposomes are the most widely used vesicular structures, solid lipid nanoparticles and nano-structured lipid carriers are non-vesicular nanocarriers. These nanocarriers have many medical uses, such as cancer therapy, gene therapy, photodynamic therapy, treatment of infectious diseases and neurodegenerative diseases, vaccines, imaging, etc. It is essential that the synthesis method of lipid-based nanocarriers and the components from which they are composed are selected in accordance with the medical application area and characterization studies are carried out. In this article, liposomes, solid lipid nanoparticles and nano-structured lipid carriers will be discussed as lipid-based nanocarriers, synthesis and characterization methods will be emphasized and examples from medical applications will be given.

Publisher

BENTHAM SCIENCE PUBLISHERS

Reference119 articles.

1. Patidar A.; Thakur D.S.; Kumar P.; Verma J.; A review on novel lipid based nanocarriers. Int J Pharm Pharm Sci 2010.,2(4),30-35

2. Dhiman N.; Awasthi R.; Sharma B.; Kharkwal H.; Kulkarni G.T.; Lipid nanoparticles as carriers for bioactive delivery. Front Chem 2021.,9,580118

3. Rawal S.U.; Patel M.M.; Lipid Nanocarriers for Drug Targeting 2018.,49-138

4. Shukla T.; Upmanyu N.; Pandey P.S.; Gosh D.; Lipid Carriers for Drug Targeting 2018.,1-47

5. Mehanna M.; Motawaa A.; Samaha M.; Pharmaceutical particulate carriers: Lipid: Based carriers. Natl J Physiol Pharm Pharmacol 2012.,2(1),10-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3